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The identification of a neuropathic component to subacromial pain may lead to different pain
management strategies. The purpose of this study was to adapt the Dutch modified painDE-
TECT (mPDQ-NL) Knee, which discriminates between nociceptive and neuropathic pain, to
fit patients with subacromial pain syndrome and subsequently assess its validity and
reliability.
Methods
The mPDQ-NL Knee was adapted into the mPDQ-NL Shoulder to fit and use for patients
with subacromial pain syndrome. The study population consisted of patients suffering from
subacromial pain syndrome who were asked to fill in the Dutch mPDQ-NL Shoulder, the
self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) and
the Disabilities of the Arm, Shoulder and Hand (DASH) to determine construct validity (struc-
tural validity, hypotheses testing) of the mPDQ-NL Shoulder. Regarding reliability, internal
consistency was determined and the mPDQ-NL Shoulder was assessed a second time with
a two-week interval to determine measurement error and reliability.
Results
A total of 107 patients were included in the validity analysis and 58 in the reliability analysis.
Validity (86% of predefined hypotheses met), internal consistency (Cronbach’s alpha 0.8)
and reliability (ICC 0.7) of the mPDQ-NL Shoulder were good, however, a systematic bias
might be present.
Conclusion
The mPDQ-NL Shoulder was successfully modified from the mPDQ-NL Knee. This study
shows that the mPDQ-NL Shoulder seems to reflect neuropathic-like pain symptoms
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experienced by patients with SAPS. Whether it may also be used as a tool to record change
over time or after treatment has to be further assessed.
Introduction
Subacromial pain syndrome (SAPS) is a common cause of shoulder pain, with a high societal
burden [1,2]. There are many contributing pathologies, including subacromial bursitis, rotator
cuff tendinopathy, partial thickness rotator cuff tears and concomitant degenerative changes
in the acromioclavicular joint [1,3]. It should be preferably treated nonoperatively, although
up to half of patients will continue to have pain after several years or have underwent surgery
[4,5]. According to the guidelines of the Dutch Orthopaedic Association, surgery can be con-
sidered after a year of conservative treatment without clinical improvement [6]. No advantage
of surgical treatment over conservative treatment has been shown [7,8].
There is growing evidence that pain in SAPS might not be purely nociceptive, but that cen-
tral sensitization can be present [9–12]. This augmented pain transmission is characterized by
local and generalized lowered pain thresholds and an exaggerated pain response to painful and
non-painful stimulation [9,11]. These manifestations may be described as neuropathic pain.
Central hypersensitivity might be associated with large numbers of patients with SAPS who
have persistent pain or a limited range of motion for several years despite treatment [4,8]. It is
essential to identify patients with SAPS with a neuropathic pain profile, as they could benefit
from additional or so far largely unexplored treatment options other than conventional noci-
ceptive pain medication or surgery, and may receive different education strategies. In the set-
ting of future research, identifying subgroups of patients with SAPS with (or without)
neuropathic features could help assess the true effectiveness of these new and already existing
treatment options. The first step toward individualized treatment, however, is a valid and reli-
able questionnaire to identify patients with neuropathic pain symptoms in SAPS.
Among existing measures, the painDETECT questionnaire appears the most appropriate
for use in SAPS to identify patients with a neuropathic pain profile; it was developed to dis-
criminate between nociceptive and neuropathic pain in adults with chronic low back pain and
has proven to be a valid and reliable screening tool [13]. It was modified by Hochman et al. to
fit patients suffering from knee osteoarthritis [14]. Rienstra et al. translated and cross-cultur-
ally adapted the questionnaire for Dutch knee osteoarthritis patients (mPDQ-NL Knee) [15].
To date, no Dutch questionnaire is available to discriminate between nociceptive and neuro-
pathic pain for patients with SAPS. Hence the objectives of this study were to modify the
Dutch mPDQ-NL Knee for use in patients with SAPS (mPDQ-NL Shoulder) and subsequently
assess its validity and reliability.
Methods
The study was approved by the Medical Ethical Committee of University Medical Center Gro-
ningen (no. METc 2015–025). The methods, particularly the statistical analyses, have been pre-
viously described by Rienstra et al. [15].
Participants
Patients suffering from SAPS who were receiving any form of conservative treatment or were
on the waiting list to undergo surgery were eligible to participate. A random sample of 309
patients with SAPS at the outpatient clinic between April 2015 and October 2016 was obtained
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from the records of the Department of Orthopedic Surgery of Martini Hospital Groningen,
The Netherlands. All patients were diagnosed with SAPS with rotator cuff tendinopathy or
chronic subacromial bursitis as contributing pathologies through anamnesis and physical and
radiological examination by their orthopedic surgeon. All patients had powerful rotator cuff
tests during physical examination. Exclusion criteria were age under 18, other shoulder pathol-
ogies (glenohumeral or acromioclavicular osteoarthritis and rotator cuff rupture were ruled
out by X-ray and ultrasound in order to provide a homogenous group), previous shoulder sur-
gery, other chronic pain disorders, severe comorbidity, cognitive or psychiatric disorders, and
inability to understand written Dutch.
Procedure
Eligible patients were mailed a letter regarding informed consent, the voluntary nature of the
study and the anonymous data-processing methods, together with the mPDQ-NL Shoulder, a
questionnaire on demographic characteristics and comorbidities, and a prepaid reply enve-
lope. To assess validity patients also received the self-completed Leeds Assessment of Neuro-
pathic Symptoms and Signs (S-LANSS) [16,17], the Disabilities of the Arm, Shoulder and
Hand (DASH) [18,19], and a Visual Analog Scale (VAS) [20]. Patients were asked to return
the completed set of questionnaires and were informed that this was considered as informed
consent to participate in the study. Patients with bilateral SAPS were asked to complete the
questionnaire for the shoulder joint that was most symptomatic. To assess reliability and mea-
surement error, a second mPDQ-NL Shoulder was sent to participants after a two-week inter-
val. In case of incomplete questionnaires or non-response, patients were contacted in order to
complete missing items or ask for their participation.
Measures and questionnaires
mPDQ-NL Shoulder. We developed the mPDQ-NL Shoulder from the Dutch mPDQ-NL
Knee by replacing the target joint “knee” with “shoulder” in every question, with a few other
minor changes related to the anatomical site (i.e. the location on the body map). The pre-final
version of the mPDQ-NL Shoulder was tested in a pilot study consisting of 20 patients with
SAPS visiting the orthopedic outpatient clinic of Martini Hospital to test for comprehensibility
of the questionnaire. No problems or comments were reported while filling out the question-
naire, measured via a response form regarding instructions, unclear questions and any addi-
tional comments. See S1 and S2 Appendices for the final mPDQ-NL Shoulder with the scoring
system.
The mPDQ-NL Shoulder is a self-report questionnaire consisting of 12 items in four com-
ponents about neuropathic pain symptoms of the left or right shoulder experienced during the
last week. The first component evaluates pain radiation using a body map. The second compo-
nent assesses pain pattern and course. In the third component pain quality is evaluated for
seven items on a six-point Likert scale (burning sensation, tingling or prickling sensation, pain
at light touch, sudden pain attacks, pain at cold or warm stimulus, numbness and pain at light
pressure). A fourth VAS component evaluates pain intensity on three items (pain at this
moment, worst pain in the past week, average pain in the past week). The total score is the sum
of the first three components and ranges from -1 to 38 points, with higher scores indicating a
more neuropathic pain profile. Cut-off points were chosen in accordance with the original
PDQ [13]. A score�12 indicates unlikely presence of a neuropathic pain component, a score
�19 indicates likely presence. A score between 13 and 18 suggests a possible neuropathic pain
profile.
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S-LANSS. The Self-Completed Leeds Assessment of Neuropathic Symptoms and Signs
(S-LANSS) is an English-validated and reliable self-report questionnaire to identify pain of
predominantly neuropathic origin in patients with chronic pain from any cause [16,17]. It
consists of seven items and uses a weighted binary scoring system. The first five items address
neuropathic pain symptoms, the last two are related to clinical signs where gently rubbing and
pressing the painful area is compared with a non-painful area. The total score ranges from 0 to
24 points. A score of�12 suggests pain of predominantly neuropathic origin. The S-LANSS
has not been specifically validated for patients with SAPS [17,21,22]. The Dutch version of the
S-LANSS used in the present study was translated and cross-culturally adapted according to
international guidelines [23].
DASH outcome measure. The Disabilities of the Arm, Shoulder and Hand (DASH) is a
30-item valid and reliable self-report questionnaire that measures physical function and symp-
toms of the past week on a 5-point Likert scale in people with any of several musculoskeletal
disorders of the upper limb [18,19]. The total score ranges from 0 to 100 points and a higher
score indicates greater disability.
VAS pain. Visual Analogue Scales (VAS) are widely used to measure pain. Patients place a
marking on a horizontal line that represents their pain, where the left end of the line represents
“no pain at all” and the right end “worst pain imaginable”. The found value was rounded up
and represents the pain score. Patients were asked to record average shoulder pain at rest and
during physical activity for the last week. VAS scales have been reported as valid and reliable
measures for pain intensity [20].
Statistical analyses
Based on Cosmin guidelines a sample size of at least 100 is considered excellent for studies on
measurement properties of questionnaires; a sample size of 50 is considered adequate for
determining test-retest reliability [24]. Hence we planned a sample size of at least 100 partici-
pants to assess the construct validity of the mPDQ-NL Shoulder, and a sample size of at least
50 to establish the test-retest reliability. Patients were subsequently asked to participate.
Statistical analyses were conducted using IBM SPSS, version 22.0 (SPSS Inc., Chicago). A p-
value <0.05 was considered to indicate statistical significance. When missing items were pres-
ent on the mPDQ-NL Shoulder, total score could not be determined. Missing items of the
DASH and S-LANSS were treated according to the guidelines proposed by the developers of
the used questionnaires. If patients reported no pain on all three VAS items of the fourth com-
ponent of the mPDQ-NL Shoulder, they were excluded from the analyses. Patient characteris-
tics were reported using descriptive statistics.
Kruskall Wallis tests were used to assess differences between subgroups based on the
mPDQ-NL Shoulder scores (� 12 points, 13–18 points and� 19 points). Posthoc analyses
were performed with Mann-Whitney U tests to determine between groups differences. Cor-
rection for multiple comparisons was done by a Bonferroni correction and resulted in a signifi-
cance level of 0.05/18 tests = 0.003.
Construct validity. Validity of the Dutch m-PDQs was expressed in terms of construct
validity due to absence of a gold standard. Construct validity is used to determine how well a
test measures what it is supposed to measure [25].
Structural validity. Structural validity refers to the degree to which items of a questionnaire
measure the dimensionality of the construct. While the original PDQ measured pain in
patients with chronic low back pain, it had to be investigated whether the items of the
mPDQ-NL Shoulder reflect the neuropathic-like symptoms of patients with SAPS. The origi-
nal PDQ measured two determinative components [13]. Exploratory factor analysis, using
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Kaiser’s criterion with varimax rotation, was conducted to determine whether the items on the
questionnaire form one single overall factor or several [25]. Factors with eigenvalues�1.00
were selected; an eigenvalue�1 explains more variance than a single observed variable [26].
Hypotheses testing. The mPDQ-NL Shoulder was compared with the S-LANSS, DASH,
VAS at rest and VAS during physical activity (see Table 1 for predefined hypotheses). The con-
structs of the mPDQ-NL Shoulder and the S-LANSS are considered the most similar as they
both measure neuropathic pain components consequently we expected a strong correlation
between both questionnaires. Smaller correlations were expected between the mPDQ-NL
Shoulder and DASH, since the latter focuses mainly on disabilities during activities and not
specifically on neuropathic pain. As most patients have more pain during exercise, mainly dur-
ing overhead work which causes impingement, a higher correlation was expected between the
mPDQ-NL Shoulder and VAS pain during activities than with VAS pain at rest.
Predefined hypotheses regarding the correlations between the questionnaires were tested
using Pearson or Spearman correlation coefficients depending on normality of the distribution
of the different scales. They were interpreted according to the criteria set by Domholdt et al.,
where 0.00–0.25 represents little if any, 0.26–0.49 weak, 0.50–0.69 moderate, 0.70–0.89 strong
and 0.90–1.00 very strong correlation [27]. According to the COSMIN criteria, construct valid-
ity of the mPDQ-NL Shoulder is sufficient if 75% of predefined hypotheses are met [25,28].
Reliability.
Internal consistency. The degree of the interrelatedness among the items of the mPDQ-NL
Shoulder was determined by calculating the Cronbach’s Alpha for the overall score on the
questionnaire and for the VAS pain score [13,29,30]. Good internal consistency is generally
considered when Cronbach’s alpha lies between 0.70 and 0.95 [25].
Measurement error. Absolute measurement errors were determined by first calculating the
standard error of measurement (SEM), which can be derived by dividing the standard devia-
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agreement was assessed using the Bland and Altman method [33] by calculating the mean dif-
ference between test and retest using the 95% CI interval, where zero lying within the 95% CI
interval is considered as absolute agreement and zero lying outside the 95% CI interval indi-
cates a systematic bias.
Reliability. Reliability was assessed using intraclass correlation coefficients (ICC) with the
corresponding 95% confidence interval (CI) for the total score of the mPDQ-NL Shoulder.
The ICC two-way random effects model, type agreement [34], was used. In general, an ICC
value >0.70 indicates high reliability [24].
Table 1. A priori hypotheses and found correlations between the mPDQ-NL Shoulder and the S-LANSS, DASH, VAS at rest and VAS during physical exercise.
Expected correlation Found correlation Hypotheses confirmed
S-LANSS 0.70–0.89 0.55 No
Higher than VAS physical activity Yes
Higher than DASH Yes
DASH 0.26–0.49 0.46 Yes
Lower than VAS physical activity Yes
VAS at rest 0.26–0.49 0.36 Yes
VAS physical activity 0.50–0.69 0.50 Yes
https://doi.org/10.1371/journal.pone.0211880.t001
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Floor and ceiling effects. Floor and ceiling effects were inspected. They are present when
15% of the participants achieve the minimum or maximum scores, respectively. This reduces
the validity and reliability of an instrument, as participants with extreme scores cannot be dis-
tinguished from each other [25].
Results
In total, 309 patients were approached to participate in the study; 121 patients (39%) returned
the questionnaires, 107 (35%) of whom were included in the validity and reliability analysis.
For the reliability study 102 patients were approached. The response rate for the reliability
analysis was 71 participants (70%), 58 (57%) of whom were included in the analysis. Two
patients were excluded from the analysis, since an intervention was carried out between test-
retest periods. At the first measurement, the number of cases lost because of missing items was
12 out of 121 respondents (10%). For the second assessment of the questionnaire this was 9
out of 71 respondents (13%). Flow chart for inclusion is shown in Fig 1.
Patient characteristics are presented in Table 2. Total scores of the questionnaires are pre-
sented in Table 3. A total of 20 (17%) patients show a likely neuropathic pain profile
(mPDQ-NL Shoulder score�19) and 28 (24%) patients a possible neuropathic pain profile
(mPDQ-NL Shoulder score 13 to 18). The median mPDQ-NL Shoulder score differed signifi-
cantly between these profiles (p<0.001) (Table 3).
Construct validity
Structural validity. Three factors with an eigenvalue�1 were revealed with exploratory
factor analysis. The first factor contained the items burning sensation, tingling or prickling sen-
sation, pain at light touch, sudden pain attacks, pain at cold or warm stimulus, numbness and
pain at light pressure. The second factor consisted of one item, pain pattern, and the third fac-
tor consisted of pain radiation using a body map. See Table 1 in S4 Appendix for the factor
loadings and distribution among components.
Hypotheses testing. The correlations between the mPDQ-NL Shoulder and the S-LANSS,
DASH, VAS pain at rest and VAS pain during physical activity are presented in Table 1, all
correlations were significant (P<0.001). A moderate correlation (0.55) was seen between the
mPDQ-NL Shoulder and the S-LANSS and VAS physical activity. Weak correlations (0.36–
0.47) were seen between the mPDQ-NL Shoulder and the DASH and VAS pain at rest. Of all
predefined hypotheses, 86% could be confirmed.
Reliability
Internal consistency. Cronbach’s alphas were 0.8 for the overall mPDQ-NL Shoulder
questionnaire, and 0.9 for the VAS pain score.
Measurement error and reliability. Reliability measures for the mPDQ-NL Shoulder are
presented in Table 4. For the total mPDQ-NL Shoulder score, SEM was 3.4, SDCind 9.5 and
SDCgroup 1.2. The mean difference of the mPDQ-NL Shoulder total score between test and
retest was -1.1 and the corresponding 95% CI did not contain zero, indicating systematic bias.
The Bland Altman plot is presented in Fig 2. ICC value of the total score was 0.7.
Floor and ceiling effects
No floor (lowest score: 2%, n = 2) or ceiling effects (highest score: 0%, n = 0) were seen for the
total mPDQ-NL Shoulder score. No ceiling effects were seen in any of the items.
m-PDQ-NL Shoulder for subacromial pain syndrome
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Fig 1. Flowchart showing patient inclusion.
https://doi.org/10.1371/journal.pone.0211880.g001
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Subgroups
Analyses of the subgroups showed a significant difference based on scores of the mPDQ-NL
Shoulder (X2 = 86.6; df = 2; p<0.001). Baseline characteristics and differences of the posthoc
analyses of the subgroups are shown in Table 5. Gender and age showed no significant differ-
ences between the subgroups.
Discussion
This study is the first to provide a Dutch mPDQ to fit patients with SAPS with a first step
toward individualized treatment, and to assess its construct validity and reliability. It shows to
be a valid and fairly reliable patient-reported instrument for identifying patients with SAPS
with a possible neuropathic pain component.
Overall validity of the mPDQ-NL Shoulder can be considered good, meaning that the ques-
tionnaire measures what it intends to. The findings of the present study regarding structural
validity of the mPDQ-NL Shoulder are in line with the Japanese, Turkish and Spanish PDQs
and the Dutch modified PDQ Hip and Knee, although some small differences were seen with
respect to factor loadings [15,29,30,35]. The mPDQ-NL Shoulder exists of three factors com-
pared to two in the original PDQ. However, the second and third factor—both existing of one
item—make up the second factor in the original version. In this version Freyenhagen et al
emphasize the relevance of the first factor [13].
Construct validity of the mPDQ-NL Shoulder was good, with 86% of the predefined
hypotheses confirmed. The highest correlation was expected between mPDQ-NL Shoulder
and the S-LANSS, as both measure neuropathic pain components [36], and also based on the
results of a previous study by Hochman et al. [37]. Yet only a moderate correlation was found.
This might be explained by some important differences between the two instruments, i.e. the
Likert items in the joint-specific mPDQ-NL Shoulder with equal weighting system versus the
binary items in the S-LANSS, used for any cause of chronic pain, with a weighted scoring sys-
tem. However, the found correlation is in line with the Dutch modified PDQ Hip and Knee
[38].
Regarding reliability, internal consistency, measurement error and reliability were assessed.
Internal consistency was good (Cronbach’s alpha 0.8). Cronbach’s alpha of the original PDQ
was not available for comparison.
Table 2. Baseline characteristics.
Included patients (n = 107) Non-responders (n = 186)
Age (years) 53 ± 9 (24–77) 56 ± 12 (26–85)
Gender
Male 48 (45%) 86 (46%)
Female 59 (55%) 100 (54%)
Body mass index (kg/m2) 27 ± 4 (17–44) ��
Duration of pain (months)� 24 (3–240) ��
Pain present in dominant arm ��
Left 9 (8.8%)
Right 29 (28.4%)
Mean ± SD (min-max) are shown for variables with normal distribution.
� Median (IQ range) is shown for variables with non-normal distribution. Gender and pain are shown as number of
patients (%).
�� No information known.
https://doi.org/10.1371/journal.pone.0211880.t002
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With a range for the total mPDQ-NL Shoulder score from -1 to 38 points, a 3.4 SEM seems
acceptable. An SDC value at the individual level of 9.5 and a low SDC value at the group level
of 1.2 indicate that the mPDQ-NL Shoulder might be useful for group comparisons rather
than detecting changes at the individual level. To distinguish clinically important changes
from measurement errors, the SDC values should be smaller than the minimal important
change (MIC) [25]. As the MIC of the painDETECT has not yet been determined, it was not
possible to properly assess whether the SEM and SDC values are acceptable. Overall, the SEM
and SDC values were comparable to the findings of Rienstra et al. for the mPDQ Hip and
Knee [15]. Although the corresponding 95% CI of the mean difference of the mPDQ-NL
Shoulder total score between the two measurements almost reached zero (-2.4 to -0.03), it did
not contain zero, indicating a possible systematic measurement bias between test and retest.
This bias might be related to the varying levels of pain intensity over time in patients with sub-
acromial pain. In addition, reliability was good with an ICC of 0.7, although previous reliability
studies of the Japanese and Spanish PDQ and the Dutch mPDQ-NL Hip and Knee show over-
all ICCs of 0.90–0.94 [15,29,30]. We did use a recommended time interval of two weeks, and
in this rather small period no change in the complaints pattern was to be expected. However,
as we did not use a global rating of change score to quantify improvement or deterioration in
the patient’s health condition between test and retest, we cannot ensure that no actual change
occurred. This might explain the systematic measurement bias and the lower ICC in compari-
son to other studies.
Table 3. Descriptive statistics questionnaires.
Questionnaire Total score on questionnaire Min Max
mPDQ-NL Shoulder total score (n = 107) 13.3 ± 6.6 0 33
Score� 12 (n = 58) 9.0 (IQR = 4.0) �
Score 13–18 (n = 29) 16.0 (IQR = 3.0) �
Score� 19 (n = 20) 22.0 (IQR = 6.5) �
S-LANSS total score(n = 102) 8.0 (IQR = 8.0) � 0 24
DASH total score (n = 98) 45.4 ± 21.3 4 88
VAS pain at rest (n = 107) 4.1 ± 2 0 10
VAS pain during physical activity (n = 107) 66.7 ± 2.1 1 10
Mean ± SD are shown for variables with normal distribution.
� Median and Interquartal range (IQR) are shown for variables with non-normal distribution.
https://doi.org/10.1371/journal.pone.0211880.t003
Table 4. Measurement error and reliability of mPDQ-NL Shoulder (n = 58).
Baseline mean ± SD 13.3 ± 6.6
Retest mean ± SD 11.2 ± 5.9




ICC (95% CI) 0.7 (0.5–0.8)
SD: standard deviation; CI: confidence interval; SEM: standard error of measurement; SDCind: smallest detectable
change at the individual level; SDCgrp: smallest detectable change at the group level; ICC: intraclass correlation
coefficient.
https://doi.org/10.1371/journal.pone.0211880.t004
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No significant floor and ceiling effects were observed for total mPDQ-NL Shoulder scores.
The floor and ceiling effects of our study are comparable with those found for the mPDQ-NL
Hip and Knee [15].
With the development of the mPDQ-NL Shoulder we can now identify patients with a neu-
ropathic pain profile in SAPS. Patients with other chronic pain conditions might be more at
risk to also develop a neuropathic pain syndrome of the shoulder. As we excluded them in the
current study, this needs to be addressed in further research. A limitation of our study is the
use of the S-LANSS in the validation study, which is validated for English but translated into
Dutch according to the guidelines of Beaton for this purpose. Furthermore, the study has a
high rate of non-responders, but demographics (age and gender) of these patients are compa-
rable to those of the included patients. A reason for not responding might be having mailed
the questionnaires without informing the patient in person at the outpatient clinic. Moreover,
as we did not investigate responsiveness, whether the tool can record change over time with a
Fig 2. Bland Altman plot. Bland Altman plot with 95% confidence interval (CI). Vertical axis: difference between mPDQ-NL Shoulder test and retest.
Horizontal axis: mean mPDQ-NL Shoulder when combining test and retest. The black horizontal line represents the mean difference between test and retest.
The gray lines represent the 95% CI of this mean difference of the mPDQ-NL Shoulder. The dotted lines represent the limits of agreement.
https://doi.org/10.1371/journal.pone.0211880.g002
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sensitivity-to-change analysis has to further assessed. In addition, we did not use neurological,
electrophysiological or psychophysical tests to demonstrate the presence of neuropathic pain
in our population. Such tests have been used before in other validation studies. Though, these
show that, for example, pain pressure thresholds seem to measure different aspects of the pain
experience compared to patient-reported assessment of pain experience [38].
Identification of patients with a neuropathic pain profile has important implications, espe-
cially considering this population is perhaps larger than expected, with 41% of patients show-
ing a possible or likely neuropathic pain profile in the current study. In addition, these patients
with a neuropathic pain profile tended to experience more symptoms. The subgroup analyses
showed a significant difference in reported pain between patients without or a possible neuro-
pathic pain profile compared to patients with a likely neuropathic pain profile. Higher
reported pain in patients could predict to patients with a neuropathic pain pattern in SAPS. As
a result it may facilitate customized treatment, with different kinds of neuromodulating medi-
cation, and it may prevent unwanted surgery. In future research, it may assist in assessing the
true effectiveness of treatment when stratification of patients with and without neuropathic
pain-like symptoms is possible.
Conclusion
The mPDQ-NL Knee was adapted to fit Dutch patients with SAPS. It shows good construct
validity, internal consistency and reliability. However, a systemic bias might be present. To
conclude, this study showed that the mPDQ-NL Shoulder seems to reflect neuropathic-like
pain symptoms experienced by patients with SAPS. Whether it also may be used as a measure
to record change over time or after treatment has to be further assessed.


















Age 55 ± 10 54 ± 9 51 ± 11 X2 = 2.4; df = 2;
P = 0.30
Gender X2 = 0.2; df = 2;
P = 0.90
Male 27 (46.6%) 12 (41.4%) 9 (45.0%)
Female 31 (53.4%) 17 (58.6%) 11 (55.0%)
BMI 27 ± 5 (18–
45)
26 ± 4 (18–
33)








X2 = 22.2; df = 2;
P<0.001
U = 444.5; Z = -3.1;
P = 0.002
U = 191.5; Z = -4.3;
P<0.001
U = 197.5; Z = -1.7;
P = 0.08
DASH 37.9 ± 19.6�� 47.6 ± 20.8�� 63.9 ± 14.5�� X2 = 19.3; df = 2;
P<0.001
U = 532.5; Z = -1.9;
P = 0.06
U = 152.5; Z = -4.3;
P<0.001
U = 132.5; Z = -2.6;
P = 0.01
VAS pain at rest 3.4 ± 2.6�� 3.6 ± 1.9�� 6.8 ± 1.9�� X2 = 23.6; df = 2;
P<0.001
U = 763; Z = -0.7;
P = 0.5
U = 200; Z = -4.4;
P<0.001
U = 68; Z = -4.6;
P<0.001
VAS pain during activity 6.0 ± 2.2�� 6.8 ± 1.5�� 8.6 ± 1.1�� X2 = 26.0; df = 2;
P<0.001
U = 691.5; Z = -1.4;
P = 0.2
U = 161; Z = -4.9;
P<0.001
U = 98; Z = -4.0;
P<0.001
� Median and Interquartal range (IQR) are shown for variables with non-normal distribution
�� Mean ± SD are shown for variables with normal distribution
��� X2 = Chi-square distribution
df = degrees of freedom
# U = Mann-Whitney U test
Z = z-score; Bold/italic: significant difference, p-value corrected for multiple comparisons, corrected p-value = P< 0.003.
https://doi.org/10.1371/journal.pone.0211880.t005
m-PDQ-NL Shoulder for subacromial pain syndrome
PLOS ONE | https://doi.org/10.1371/journal.pone.0211880 February 6, 2019 11 / 14
Supporting information
S1 Appendix. mPDQ-NL Shoulder left.
(PDF)
S2 Appendix. mPQD-NL shoulder right.
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